Prior studies evaluating the XPO1 inhibition in a panel of sensitive and resistant cell lines found that intrinsic cellular resistance was not attributed to XPO1 occupancy by selinexor, suggesting that cancer cell responsiveness to XPO1 inhibition depends on the modulation of signalling pathways downstream of XPO1.40 Here, XPO1 is linked to cancer.